Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-45l2p Total loading time: 0 Render date: 2024-04-29T12:15:39.373Z Has data issue: false hasContentIssue false

Fas (CD95) and Fas-ligand (CD95L)

from Section 1 - Antibodies

Published online by Cambridge University Press:  27 October 2016

Edited by
Runjan Chetty ,
Kumarasen Cooper  and
Allen M. Gown
Runjan Chetty
Affiliation:
University of Toronto
Kumarasen Cooper
Affiliation:
University of Pennsylvania
Allen M. Gown
Affiliation:
Phenopath Laboratories, Seattle
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Leong's Manual of Diagnostic Antibodies for Immunohistology , pp. 221 - 222
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Selected references

Bamberger, AM, Schulte, HM, Thuneke, I, et al. Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. Journal of Clinical Endocrinology and Metabolism 1997; 82: 3173–5.CrossRefGoogle ScholarPubMed
De la Monte, SM, Sohn, YK, Wands, JR. Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease. Journal of Neurological Sciences 1997; 152: 73–83.CrossRefGoogle ScholarPubMed
Hellquist, HB, Olejnicka, B, Jadner, M, et al. Fas receptor is expressed in human lung squamous cell carcinomas, whereas bcl-2 and apoptosis are not pronounced: a preliminary report. British Journal of Cancer 1997; 76: 175–9.CrossRefGoogle Scholar
Kazufumi, M, Sonoko, N, Masanori, K, et al. Expression of bcl-2 protein and APO-1 (Fas antigen) in the lung tissue from patients with idiopathic pulmonary fibrosis. Microscopy Research Technology 1997; 38: 480–7.3.0.CO;2-M>CrossRefGoogle ScholarPubMed
Lee, J, Richburg, JH, Younkin, SC, Bockelheide, K. The Fas system is a key regulator of germ cell apoptosis in the testis. Endocrinology 1997; 138: 2081–8.CrossRefGoogle ScholarPubMed
Nichans, GA, Brunner, T, Frizelle, SP, et al. Human lung carcinomas express Fas ligand. Cancer Research 1997; 57: 1007–12.Google Scholar
Nonomura, N, Mild, T, Yokoyama, M, et al. Fas/APO-1-mediated apoptosis of human renal cell carcinoma. Biochemistry Biophysiology Research Communications 1996; 229: 945–51.Google ScholarPubMed
Sheard, MA, Vojtesek, B, Janakova, L, et al. Up-regulation of Fas (CD95) in human p53 wild-type cancer cells treated with ionizing radiation. International Journal of Cancer 1997; 73: 757–62.3.0.CO;2-1>CrossRefGoogle ScholarPubMed
Shukuwa, T, Katayama, I, Koji, T. Fas-mediated apoptosis of melanoma cells and infiltrating lymphocytes in human malignant melanomas. Modern Pathology 2002; 15: 387–96.CrossRefGoogle ScholarPubMed
Strater, J, Wellisch, I, Riedl, S, et al. CD95 (APO-l/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology 1997; 113: 160–7.CrossRefGoogle Scholar
Tachibana, O, Lampe, J, Kleihues, P, Obgaki, H. Preferential expression of Fas/APOl (CD95) and apoptotic cell death in perinecrotic cells of glioblastoma multiforme. Acta Neuropathologica (Berlin) 1996; 92: 431–4.CrossRefGoogle Scholar
Uckan, D, Steele, A, Wang, BY, et al. Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion. Molecular Human Reproduction 1997; 3: 655–62.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×